share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga ·  Nov 16 05:06

Gainers

  • CERo Therapeutics Hldgs (NASDAQ:CERO) stock increased by 71.0% to $0.32 during Friday's pre-market session. The company's market cap stands at $48.1 million.
  • QT Imaging Holdings (NASDAQ:QTI) shares moved upwards by 18.58% to $0.58. The company's market cap stands at $12.4 million. As per the news, the Q3 earnings report came out 2 days ago.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 18.02% to $0.77.
  • Alpha Teknova (NASDAQ:TKNO) stock rose 14.17% to $7.49. The market value of their outstanding shares is at $399.2 million.
  • Gain Therapeutics (NASDAQ:GANX) shares rose 14.04% to $1.99. The market value of their outstanding shares is at $50.8 million. As per the news, the Q3 earnings report came out yesterday.
  • iSpecimen (NASDAQ:ISPC) stock increased by 14.02% to $4.96. The market value of their outstanding shares is at $4.7 million.

Losers

  • TFF Pharmaceuticals (NASDAQ:TFFP) shares fell 71.9% to $0.45 during Friday's pre-market session. The market value of their outstanding shares is at $1.5 million.
  • Eyenovia (NASDAQ:EYEN) shares decreased by 60.02% to $0.14. The market value of their outstanding shares is at $11.6 million. As per the news, the Q3 earnings report came out 3 days ago.
  • Akoya Biosciences (NASDAQ:AKYA) stock declined by 31.31% to $2.15. The market value of their outstanding shares is at $106.4 million. As per the news, the Q3 earnings report came out yesterday.
  • GRI Bio (NASDAQ:GRI) shares declined by 20.85% to $0.76. The market value of their outstanding shares is at $2.8 million. As per the news, the Q3 earnings report came out yesterday.
  • Tivic Health Systems (NASDAQ:TIVC) shares declined by 17.66% to $0.3. The company's market cap stands at $1.8 million. As per the press release, Q3 earnings came out yesterday.
  • Carmell (NASDAQ:CTCX) shares decreased by 13.44% to $0.24. The company's market cap stands at $5.1 million. As per the news, the Q3 earnings report came out yesterday.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment